|
Recent Developments |
|
31-MAY-13
During the quarter, the profit of the company fell 18.60% to Rs 4.88 million from Rs 9.56 million in the same quarter previous year.
Future Plans
The company is eying African and Latin American countries for exporting its products subject to obtainment of certificates. These markets have good opportunities as there the cost of production is very high, and they rely on importing medicines from countries like India.
... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2003 (12) | 31-Mar-2002 (12) | 31-Mar-2001 (12) | | Net sales | 148.87 | 336.94 | 201.20 | | Other Income | 18.90 | 39.55 | 0.10 | | Total Income | 167.77 | 376.49 | 201.30 | | Cost of goods sold | 126.64 | 315.91 | 173.60 | | OPBDIT | 41.13 | 60.58 | 27.70 | | PAT | 24.61 | 46.57 | 14.70 | | Gross Block | - | - | - | | Equity capital | 90.81 | 90.81 | 0.00 | | EPS (Rs.) | 0.00 | 0.00 | 0.00 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | NA | NA | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 24.5 | 16.1 | 13.8 | | Net margin (% of OI) | 14.7 | 12.4 | 7.3 |
|
|
Detailed Financials
|
|
|
|
|
